Application Nr Approved Date Route Status External Links
ANDA205473 2015-07-29 Intravenous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Ethacrynate Sodium Is Indicated For Treatment Of Edema When An Agent With Greater Diuretic Potential Than Those Commonly Employed Is Required. 1.treatment Of The Edema Associated With Congestive Heart Failure, Cirrhosis Of The Liver, And Renal Disease, Including The Nephrotic Syndrome. 2.short-Term Management Of Ascites Due To Malignancy, Idiopathic Edema, And Lymphedema. 3.short-Term Management Of Hospitalized Pediatric Patients, Other Than Infants, With Congenital Heart Disease Or The Nephrotic Syndrome. 4.intravenous Ethacrynate Sodium Is Indicated When A Rapid Onset Of Diuresis Is Desired, E.g., In Acute Pulmonary Edema, Or When Gastrointestinal Absorption Is Impaired Or Oral Medication Is Not Practicable.

All Formulated Excipients (1 Total)

Name Structure Kind Function Status
1. Mannitol MANNITOL Molecular NUTR-Nutrient GRAS-Generally recognized as safe.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ethacrynate Sodium ETHACRYNATE SODIUM ZINC1382